Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David K Raynor

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Plos One|October 8, 2015
How to Test Mandatory Text Templates: The European Patient Information LeafletHenk Pander Maat, Leo Lentz, David K Raynor
Therapeutic Innovation & Regulatory Science|September 20, 2018
The Effectiveness of the Summary of Product Characteristics (SmPC) and Recommendations for ImprovementDavid K Raynor, Peter De Veene, David Bryant
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 7, 2012
Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in AustraliaKim K Hamrosi, Parisa Aslani, David K Raynor
Research in Social & Administrative Pharmacy : RSAP|April 10, 2013
Pharmacist and general practitioner ambivalence about providing written medicine information to patients-a qualitative studyKim K Hamrosi, David K Raynor, Parisa Aslani
Research in Social & Administrative Pharmacy : RSAP|November 19, 2013
Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?Kim K Hamrosi, David K Raynor, Parisa Aslani
BMC Health Services Research|April 24, 2014
Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitatorsKim K Hamrosi, David K Raynor, Parisa Aslani
Therapeutic Innovation & Regulatory Science|May 30, 2018
Comparison of International Regulations for Written Medicine Information (WMI) on Prescription MedicinesHsiu-Chun Tony Yuan, David K Raynor, Parisa Aslani
The International Journal of Pharmacy Practice|July 14, 2016
How much information about the benefits of medicines is included in patient leaflets in the European Union? - A surveyRebecca Dickinson, David K Raynor, Peter Knapp, et al.
BMJ Open|December 4, 2016
Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefsRebecca Dickinson, David K Raynor, Peter Knapp, et al.
Patient Education and Counseling|May 14, 2004
We are the experts: people with asthma talk about their medicine information needsDavid K Raynor, Imogen Savage, Peter Knapp, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Plos One|October 8, 2015
How to Test Mandatory Text Templates: The European Patient Information LeafletHenk Pander Maat, Leo Lentz, David K Raynor
Therapeutic Innovation & Regulatory Science|September 20, 2018
The Effectiveness of the Summary of Product Characteristics (SmPC) and Recommendations for ImprovementDavid K Raynor, Peter De Veene, David Bryant
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 7, 2012
Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in AustraliaKim K Hamrosi, Parisa Aslani, David K Raynor
Research in Social & Administrative Pharmacy : RSAP|April 10, 2013
Pharmacist and general practitioner ambivalence about providing written medicine information to patients-a qualitative studyKim K Hamrosi, David K Raynor, Parisa Aslani
Research in Social & Administrative Pharmacy : RSAP|November 19, 2013
Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?Kim K Hamrosi, David K Raynor, Parisa Aslani
BMC Health Services Research|April 24, 2014
Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitatorsKim K Hamrosi, David K Raynor, Parisa Aslani
Therapeutic Innovation & Regulatory Science|May 30, 2018
Comparison of International Regulations for Written Medicine Information (WMI) on Prescription MedicinesHsiu-Chun Tony Yuan, David K Raynor, Parisa Aslani
The International Journal of Pharmacy Practice|July 14, 2016
How much information about the benefits of medicines is included in patient leaflets in the European Union? - A surveyRebecca Dickinson, David K Raynor, Peter Knapp, et al.
BMJ Open|December 4, 2016
Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefsRebecca Dickinson, David K Raynor, Peter Knapp, et al.
Patient Education and Counseling|May 14, 2004
We are the experts: people with asthma talk about their medicine information needsDavid K Raynor, Imogen Savage, Peter Knapp, et al.
Pageof 6